{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:54:44Z","timestamp":1775523284977,"version":"3.50.1"},"reference-count":43,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,25]]},"DOI":"10.20945\/2359-3997000000330","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T18:28:37Z","timestamp":1615314517000},"source":"Crossref","is-referenced-by-count":2,"title":["Clinical utility of TGFB1 and its receptors (TGFBR1 and TGFBR2) in thyroid nodules: evaluation based on single nucleotide polymorphisms and mRNA analysis"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3253-371X","authenticated-orcid":false,"given":"Karina Colombera","family":"Peres","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5584-8429","authenticated-orcid":false,"given":"Larissa","family":"Teodoro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-4696","authenticated-orcid":false,"given":"La\u00eds Helena Pereira","family":"Amaral","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3052-1451","authenticated-orcid":false,"given":"Elis\u00e2ngela Souza","family":"Teixeira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-6035","authenticated-orcid":false,"given":"Icl\u00e9ia Siqueira","family":"Barreto","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5869-0791","authenticated-orcid":false,"given":"Leandro Luiz Lopes de","family":"Freitas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-8356","authenticated-orcid":false,"given":"Valdemar","family":"Maximo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-6761","authenticated-orcid":false,"given":"L\u00edgia V. Montalli","family":"Assump\u00e7\u00e3o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-8913","authenticated-orcid":false,"given":"Natassia Elena","family":"Bufalo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-3220","authenticated-orcid":false,"given":"Laura Sterian","family":"Ward","sequence":"additional","affiliation":[]}],"member":"8510","reference":[{"key":"key20210309132827_B1","year":"2019","unstructured":"1. Estimate\/2020 \u2013 Cancer Incidence in Brazil [Internet]. 2019. Available from: http:\/\/www1.inca.gov.br\/estimativa\/2019\/. Accessed 23 March 2020","journal-title":"Estimate\/2020 \u2013 Cancer Incidence in Brazil [Internet]"},{"issue":"9","key":"key20210309132827_B2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.2018.0898","article-title":"The Diagnosis and Management of Thyroid Nodules: A Review","volume":"319","author":"Durante","year":"2018","unstructured":"2. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018;319(9):914-24.","journal-title":"JAMA"},{"issue":"3","key":"key20210309132827_B3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bjps.2003.12.012","article-title":"What is transforming growth factor-beta (TGF-beta)?","volume":"57","author":"Chin","year":"2004","unstructured":"3. Chin D, Boyle GM, Parsons PG, Coman WB. What is transforming growth factor-beta (TGF-beta)? Br J Plast Surg. 2004;57(3):215-21.","journal-title":"Br J Plast Surg"},{"issue":"6","key":"key20210309132827_B4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","unstructured":"4. Shi Y, Massagu\u00e9 J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685-700.","journal-title":"Cell"},{"issue":"6","key":"key20210309132827_B5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1535-6108(03)00135-1","article-title":"Targeting the TGF beta signaling network in human neoplasia","volume":"3","author":"Dumont","year":"2003","unstructured":"5. Dumont N, Arteaga CL. Targeting the TGF beta signaling network in human neoplasia. Cancer Cell. 2003;3(6):531-6.","journal-title":"Cancer Cell"},{"issue":"1-2","key":"key20210309132827_B6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cytogfr.2005.09.009","article-title":"Alterations in components of the TGF-beta superfamily signaling pathways in human cancer","volume":"17","author":"Levy","year":"2006","unstructured":"6. Levy L, Hill CS. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 2005\/11\/23. 2006;17(1-2):41-58.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"key20210309132827_B7","first-page":"238","article-title":"[Functional implications of single nucleotide polymorphisms (SNPs) in protein-coding and non-coding RNA genes in multifactorial diseases]","volume":"153","author":"Ram\u00edrez-Bello","year":"2017","unstructured":"7. Ram\u00edrez-Bello J, Jim\u00e9nez-Morales M. [Functional implications of single nucleotide polymorphisms (SNPs) in protein-coding and non-coding RNA genes in multifactorial diseases]. Gac Med Mex. 2017;153(2):238-50.","journal-title":"Gac Med Mex"},{"issue":"4","key":"key20210309132827_B8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1684\/ecn.2016.0382","article-title":"TGF-\u03b21 functional polymorphisms: a review","volume":"27","author":"Martelossi Cebinelli","year":"2016","unstructured":"8. Martelossi Cebinelli GC, Paiva Trugilo K, Badar\u00f3 Garcia S, Braj\u00e3o de Oliveira K. TGF-\u03b21 functional polymorphisms: a review. Eur Cytokine Netw. 2016;27(4):81-9.","journal-title":"Eur Cytokine Netw"},{"issue":"17","key":"key20210309132827_B9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2217\/pgs-2018-0070","article-title":"Genetic polymorphism contributes to 131I radiotherapy-induced toxicities in patients with differentiated thyroid cancer","volume":"19","author":"Liu","year":"2018","unstructured":"9. Liu J, Tang X, Shi F, Li C, Zhang K, Wang G, et al. Genetic polymorphism contributes to 131I radiotherapy-induced toxicities in patients with differentiated thyroid cancer. Pharmacogenomics. 2018;19(17):1335-44.","journal-title":"Pharmacogenomics"},{"key":"key20210309132827_B10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12935-018-0682-0","article-title":"Polymorphisms of TGFBR1, TLR4 are associated with prognosis of gastric cancer in a Chinese population","volume":"18","author":"He","year":"2018","unstructured":"10. He B, Xu T, Pan B, Pan Y, Wang X, Dong J, et al. Polymorphisms of TGFBR1, TLR4 are associated with prognosis of gastric cancer in a Chinese population. Cancer Cell Int. 2018;18:191.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"key20210309132827_B11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10014-006-0196-7","article-title":"Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas","volume":"23","author":"Ikeda","year":"2006","unstructured":"11. Ikeda H. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas. Brain Tumor Pathol. 2006;23(1):7-12.","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"key20210309132827_B12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1667\/RR1327.1","article-title":"Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan","volume":"171","author":"Sigurdson","year":"2009","unstructured":"12. Sigurdson AJ, Land CE, Bhatti P, Pineda M, Brenner A, Carr Z, et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res. 2009;171(1):77-88.","journal-title":"Radiat Res"},{"issue":"3","key":"key20210309132827_B13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cncr.30360","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?","volume":"123","author":"Haugen","year":"2017","unstructured":"13. Haugen BR. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed? Cancer. 2017;123(3):372-81.","journal-title":"Cancer"},{"issue":"7","key":"key20210309132827_B14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1590\/S0004-27302009000700014","article-title":"Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer","volume":"53","author":"Pitoia","year":"2009","unstructured":"14. Pitoia F, Ward L, Wohllk N, Friguglietti C, Tomimori E, Gauna A, et al. Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer. Arq Bras Endocrinol Metabol. 2009;53(7):884-7.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"key20210309132827_B15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003440","article-title":"PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations","volume":"10","author":"Bendl","year":"2014","unstructured":"15. Bendl J, Stourac J, Salanda O, Pavelka A, Wieben ED, Zendulka J, et al. PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol. 2014\/01\/16. 2014;10(1):e1003440.","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"key20210309132827_B16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral","volume":"43","author":"Tavtigian","year":"2006","unstructured":"16. Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2005\/07\/13. 2006;43(4):295-305.","journal-title":"J Med Genet"},{"issue":"4","key":"key20210309132827_B17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/prot.20810","article-title":"Prediction of protein stability changes for single-site mutations using support vector machines","volume":"62","author":"Cheng","year":"2006","unstructured":"17. Cheng J, Randall A, Baldi P. Prediction of protein stability changes for single-site mutations using support vector machines. Proteins. 2006;62(4):1125-32.","journal-title":"Proteins"},{"issue":"8","key":"key20210309132827_B18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/pro.2494","article-title":"The structural and functional signatures of proteins that undergo multiple events of post-translational modification","volume":"23","author":"Pejaver","year":"2014","unstructured":"18. Pejaver V, Hsu WL, Xin F, Dunker AK, Uversky VN, Radivojac P. The structural and functional signatures of proteins that undergo multiple events of post-translational modification. Protein Sci. 2014\/06\/11. 2014;23(8):1077-93.","journal-title":"Protein Sci. 2014\/06\/11"},{"issue":"4","key":"key20210309132827_B19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","unstructured":"19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-8.","journal-title":"Methods"},{"issue":"2","key":"key20210309132827_B20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","unstructured":"20. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2004\/08\/05. 2005;21(2):263-5.","journal-title":"Bioinformatics"},{"issue":"8","key":"key20210309132827_B21","doi-asserted-by":"crossref","DOI":"10.1177\/1010428319869096","article-title":"Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women","volume":"41","author":"Hadj-Ahmed","year":"2019","unstructured":"21. Hadj-Ahmed M, Ghali RM, Bouaziz H, Habel A, Stayoussef M, Ayedi M, et al. Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women. Tumour Biol. 2019;41(8):1010428319869096.","journal-title":"Tumour Biol"},{"issue":"8","key":"key20210309132827_B22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201775","article-title":"Transforming growth factor-\u03b21 gene promoter -509C\/T polymorphism in association with expression affects colorectal cancer development and depends on gender","volume":"13","author":"Stanilova","year":"2018","unstructured":"22. Stanilova S, Stanilov N, Julianov A, Manolova I, Miteva L. Transforming growth factor-\u03b21 gene promoter -509C\/T polymorphism in association with expression affects colorectal cancer development and depends on gender. PLoS One. 2018;13(8):e0201775.","journal-title":"PLoS One"},{"issue":"3","key":"key20210309132827_B23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.24013","article-title":"TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis","volume":"124","author":"Castillejo","year":"2009","unstructured":"23. Castillejo A, Rothman N, Murta-Nascimento C, Malats N, Garc\u00eda-Closas M, G\u00f3mez-Mart\u00ednez A, et al. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis. Int J Cancer. 2009;124(3):608-13.","journal-title":"Int J Cancer"},{"key":"key20210309132827_B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2407-4-9","article-title":"Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes","volume":"4","author":"Sigurdson","year":"2004","unstructured":"24. Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, et al. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer. 2004;4:9.","journal-title":"BMC Cancer"},{"issue":"17","key":"key20210309132827_B25","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/ddm150","article-title":"The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations","volume":"16","author":"Thys","year":"2007","unstructured":"25. Thys M, Schrauwen I, Vanderstraeten K, Janssens K, Dieltjens N, Van Den Bogaert K, et al. The coding polymorphism T263I in TGF-beta1 is associated with otosclerosis in two independent populations. Hum Mol Genet. 2007;16(17):2021-30.","journal-title":"Hum Mol Genet"},{"issue":"Pt 2","key":"key20210309132827_B26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.00229","article-title":"Making sense of latent TGFbeta activation","volume":"116","author":"Annes","year":"2003","unstructured":"26. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. 2003;116(Pt 2):217-24.","journal-title":"J Cell Sci"},{"issue":"8","key":"key20210309132827_B27","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028662","article-title":"Cancer Inflammation and Cytokines","volume":"10","author":"Galdiero","year":"2018","unstructured":"27. Galdiero MR, Marone G, Mantovani A. Cancer Inflammation and Cytokines. Cold Spring Harb Perspect Biol. 2018;10(8):a028662.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"8","key":"key20210309132827_B28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","unstructured":"28. Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Lim\u00f3n P. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010;10(8):554-67.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"key20210309132827_B29","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022236","article-title":"Regulation of the Immune Response by TGF-\u03b2: From Conception to Autoimmunity and Infection","volume":"9","author":"Sanjabi","year":"2017","unstructured":"29. Sanjabi S, Oh SA, Li MO. Regulation of the Immune Response by TGF-\u03b2: From Conception to Autoimmunity and Infection. Cold Spring Harb Perspect Biol. 2017;9(6):a022236.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"key20210309132827_B30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","unstructured":"30. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423-37.","journal-title":"Nat Med"},{"issue":"1_suppl","key":"key20210309132827_B31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1724600820906155","article-title":"Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors","volume":"35","author":"Nistic\u00f2","year":"2020","unstructured":"31. Nistic\u00f2 P, Ciliberto G. Biological mechanisms linked to inflammation in cancer: Discovery of tumor microenvironment-related biomarkers and their clinical application in solid tumors. Int J Biol Markers. 2020;35(1_suppl):8-11.","journal-title":"Int J Biol Markers"},{"issue":"4","key":"key20210309132827_B32","first-page":"375","article-title":"Transcriptional activity of TGF\u03b21 and its receptors genes in thyroid gland","volume":"67","author":"Kajdaniuk","year":"2016","unstructured":"32. Kajdaniuk D, Marek A, Marek B, Mazurek U, Fila-Dani\u0142ow A, Foltyn W, et al. Transcriptional activity of TGF\u03b21 and its receptors genes in thyroid gland. Endokrynol Pol. 2016;67(4):375-82.","journal-title":"Endokrynol Pol"},{"issue":"4","key":"key20210309132827_B33","first-page":"401","article-title":"Transforming Growth Factor Beta 1 (TGF-\u03b21) in Thyroid Cancer Patients: a View from the Peripheral Blood","volume":"46","author":"Zivancevic-Simonovic","year":"2016","unstructured":"33. Zivancevic-Simonovic S, Mihaljevic O, Mihajlovic D, Milosevic-Djordjevic O, Jovanovic Z, Mijatovic-Teodorovic L, et al. Transforming Growth Factor Beta 1 (TGF-\u03b21) in Thyroid Cancer Patients: a View from the Peripheral Blood. Ann Clin Lab Sci. 2016;46(4):401-6.","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"key20210309132827_B34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40463-014-0022-x","article-title":"Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool?","volume":"43","author":"Brace","year":"2014","unstructured":"34. Brace MD, Wang J, Petten M, Bullock MJ, Makki F, Trites J, et al. Differential expression of transforming growth factor-beta in benign vs. papillary thyroid cancer nodules; a potential diagnostic tool? J Otolaryngol Head Neck Surg. 2014;43(1):22.","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"key20210309132827_B35","doi-asserted-by":"crossref","first-page":"431718","DOI":"10.4061\/2011\/431718","article-title":"EGF and TGF-\u03b21 effects on thyroid function","volume":"2011","author":"Mincione","year":"2011","unstructured":"35. Mincione G, Di Marcantonio MC, Tarantelli C, D\u2019Inzeo S, Nicolussi A, Nardi F, et al. EGF and TGF-\u03b21 effects on thyroid function. J Thyroid Res. 2011;2011:431718.","journal-title":"J Thyroid Res"},{"issue":"10","key":"key20210309132827_B36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1055\/s-2007-978946","article-title":"Expression of Transforming Growth Factor-\u03b21 and Transforming Growth Factor-\u03b2 Type-II Receptor mRNA in Papillary Thyroid Carcinoma","volume":"30","author":"Matoba","year":"1998","unstructured":"36. Matoba H, Sugano S, Yamaguchi N, Miyachi Y. Expression of Transforming Growth Factor-\u03b21 and Transforming Growth Factor-\u03b2 Type-II Receptor mRNA in Papillary Thyroid Carcinoma. Horm Metab Res. 1998;30(10):624-8.","journal-title":"Horm Metab Res"},{"issue":"3","key":"key20210309132827_B37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02739960","article-title":"Analysis of TGF-\u03b2 and TGF-\u03b2-RII in thyroid neoplasms from the United States, Japan, and China","volume":"9","author":"Imamura","year":"1998","unstructured":"37. Imamura Y, Jin L, Grande JP, Li CY, Zheng TR, Erickson LA, et al. Analysis of TGF-\u03b2 and TGF-\u03b2-RII in thyroid neoplasms from the United States, Japan, and China. Endocr Pathol. 1998;9(3):209-216.","journal-title":"Endocr Pathol"},{"issue":"W1","key":"key20210309132827_B38","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","unstructured":"38. Tang Z, Li C, Kang B, Gao G, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-102.","journal-title":"Nucleic Acids Res"},{"key":"key20210309132827_B39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1186\/s12885-015-1993-3","article-title":"TGF-\u03b2 isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications","volume":"15","author":"Chen","year":"2015","unstructured":"39. Chen C, Zhao KN, Masci PP, Lakhani SR, Antonsson A, Simpson PT, et al. TGF-\u03b2 isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications. BMC Cancer. 2015;15:1010.","journal-title":"BMC Cancer"},{"issue":"1","key":"key20210309132827_B40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-020-0819-6","article-title":"Methylation silencing of TGF-\u03b2 receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma","volume":"12","author":"Ma","year":"2020","unstructured":"40. Ma Y, He S, Gao A, Zhang Y, Zhu Q, Wang P, et al. Methylation silencing of TGF-\u03b2 receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma. Clin Epigenetics. 2020;12(1):25.","journal-title":"Clin Epigenetics"},{"issue":"5","key":"key20210309132827_B41","first-page":"1097","article-title":"MicroRNA-133b targets TGF-\u03b2 receptor I to inhibit TGF-\u03b2-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-\u03b2\/SMAD pathway in breast cancer","volume":"55","author":"Wang","year":"2019","unstructured":"41. Wang S, Huang M, Wang Z, Wang W, Zhang Z, Qu S, et al. MicroRNA-133b targets TGF-\u03b2 receptor I to inhibit TGF-\u03b2-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-\u03b2\/SMAD pathway in breast cancer. Int J Oncol. 2019;55(5):1097-109.","journal-title":"Int J Oncol"},{"key":"key20210309132827_B42","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3389\/fonc.2019.01535","article-title":"miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer","volume":"9","author":"Qi","year":"2019","unstructured":"42. Qi JC, Yang Z, Zhang YP, Lu BS, Yin YW, Liu KL, et al. miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer. Front Oncol. 2019;9:1535.","journal-title":"Front Oncol"},{"issue":"5","key":"key20210309132827_B43","first-page":"536","article-title":"Interplay of TGF\u03b2 signaling and microRNA in thyroid cell loss of differentiation and cancer progression","volume":"63","author":"Fuziwara","year":"2019","unstructured":"43. Fuziwara CS, Saito KC, Kimura ET. Interplay of TGF\u03b2 signaling and microRNA in thyroid cell loss of differentiation and cancer progression. Arch Endocrinol Metab. 2019;63(5):536-44.","journal-title":"Arch Endocrinol Metab"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T18:29:29Z","timestamp":1615314569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972021005003202&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":43,"alternative-id":["10.20945\/2359-3997000000330"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000330","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]}}}